期刊文献+

组织因子及组织因子微粒在急性髓系白血病中的检测及临床意义 被引量:2

Detection and clinical significance of tissue factor and microparticle-associated tissue factor in acute myeloid leukemia
原文传递
导出
摘要 目的:通过检测急性髓系白血病(AML)患者血浆中组因子(TF)及组织因子微粒(MP-TF)的表达,探讨其在AML凝血异常中的临床意义。方法:选择AML住院患者64例(AML组),其中急性早幼粒细胞白血病(APL)22例,非APL 42例;并发弥散性血管内凝血(DIC)22例,未并发DIC 42例。非APL中13例治疗后骨髓完全缓解(CR),APL中15例治疗后骨髓达CR,包含12例APL并发DIC患者。对照组34例均为健康献血员。采用流式细胞术检测MP-TF,ELISA法检测血浆中TF。结果:治疗前AML组MP-TF及TF水平明显高于对照组[(60.90±14.90)%∶(45.80±12.03)%,P<0.01;(129.11±37.32)pg/ml∶(95.96±19.56)pg/ml,P<0.05]。AML组内,15例治疗后骨髓达CR的APL患者治疗前后MP-TF水平差异有统计学意义[(60.13±8.95)%∶(51.65±8.11)%,P<0.05],其中12例APL并发DIC患者治疗前MP-TF及TF水平均高于治疗后[(60.00±9.45)%∶(56.70±17.10)%;(155.67±31.14)pg/ml∶(122.03±18.41)pg/ml,均P<0.05];13例治疗后骨髓达CR的非APL患者治疗前TF明显高于治疗后[(147.61±27.43)pg/ml∶(118.73±20.23)pg/ml,P<0.01]。AML组内,凝血酶原时间(PT)延长>3s的患者(10例)MP-TF水平明显高于PT延长<3s及PT正常的患者(54例)[(64.10±9.38)%∶(59.40±19.73)%,P<0.05];纤维蛋白降解产物(FDP)异常的患者(24例)TF水平明显高于FDP正常患者(40例)[(152.26±37.89)pg/ml∶(112.81±35.47)pg/ml,P<0.05]。结论:MP-TF及TF是参与凝血异常的重要指标,MP-TF较血浆TF能更好地反映TF活性水平,且MP-TF与AML尤其是APL及其凝血异常有密切关系,可作为监测APL疾病病情缓解的有效指标之一。 Objective:To detect and explore the clinical significance of tissue factor(TF) and microparticle-associated tissue factor(MP-TF) in acute myeloid leukemia(AML) patients. Method:The peripheral blood in 64 cases of AML with newly diagnosed was collected,including 22 cases of APL,42 cases of non-APL,and 22 cases of AML with DIC and 42 cases of AML without DIC.Thirteen cases of non-APL with bone marrow complete remission(CR),15 cases of APL with bone marrow CR including 12 cases of APL with DIC.Thirty-four cases of normal controls were healthy blood donors.MP-TF was detected by FCM and TF was detected by ELISA. Result:MP-TF and TF in AML patients were both higher than those in the normal controls(P0.01,P0.05).MP-TF in the 15 cases of APL with bone marrow CR was higher before chemotherapy than that after chemotherapy(P0.05).The levels of MP-TF and TF in 12 cases of APL with DIC were higher before chemotherapy than those after chemotherapy(P0.05).TF in the 13 cases of non-APL with bone marrow CR was higher before chemotherapy than that after chemotherapy(P0.01).The MP-TF in the patients with PT3 s was higher than that with normal PT value(P0.05).TF in the patients with abnormal FDP value was increased than that with normal FDP(P0.05). Conclusion:MP-TF and TF are important indicators involved in coagulopathy,and MP-TF could better reflect the activity of TF.MP-TF is associated with haemostatic dysfunction in the AML,and it could be used as a factor to monitor disease remission.
出处 《临床血液学杂志》 CAS 2013年第4期465-468,共4页 Journal of Clinical Hematology
基金 卫生公益性行业科研专项(No:201202017)
关键词 急性髓系白血病 组织因子微粒 急性早幼粒细胞白血病 弥散性血管内凝血 acute myeloid leukemia microparticle-associated tissue factor acute promyelocytic leukemia disseminated intravascular coagulation
  • 相关文献

参考文献13

  • 1LEROYER A S, TEDGUI A, BOULANGER C M. Role of mieroparticles in atherothrombosis[J]. J Intern Med, 2008,263 .. 528- 537.
  • 2ZWICKER J I, TRENOR C C, FURIE B C, et al. Tis- sue factor bearing-microparticles and thrombus forma- tion[J]. Arterioscler Thromb Vase Biol, 2011, 31.. 728-733.
  • 3FURIE B. Pathogenesis of thrombosis[J]. Hematolo- gy Am Soc Hematol Educ Program,2009 :255-258.
  • 4方怡,蔡佳翌,钟济华,钟华,王海嵘,陈芳源.异常剪接组织因子在急性髓系白血病细胞株中的表达研究[J].中国实验血液学杂志,2011,19(2):288-292. 被引量:3
  • 5PICCIN A,MURPHY W G, SMITH O P. Circulating microparticles: pathophysiology and clinical implica- tions[J]. Blood Rev, 2007,21 : 157 - 171.
  • 6HRON G, KOLLARS M, WEBER H, et al. Tissue factor-positive microparticles:cellular origin and asso- ciation with coagulation activation in patients with colorectal cancer [J]. Thromb Haemost, 2007, 97 : 119-123.
  • 7KHORANA A A,FRANCIS C W,MENZIES K E,et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer[J]. J Thromb Haemost, 2008,6 : 1983- 1985.
  • 8ZWICKER J I,LIEBMAN H A, NEUBERG D,et a|. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in ma- lignancy[J]. Clin Cancer Res, 2009,15 : 6830- 6840.
  • 9AUWERDA J J, YUANA Y, ()SANTO S, et al. Mi- croparticle-associated tissue {actor activity and venous thrombosis in multiple myeloma[J]. Thromb and Hae- most, 2011,105 : 14-20.
  • 10唐云龙,周燕,王纯斌,秦燕,冯健,秦婧.组织因子相关血小板微粒对恶性淋巴瘤患者血栓发生的提示作用[J].中国实验血液学杂志,2012,20(2):325-328. 被引量:4

二级参考文献29

  • 1ERIKSSON T, BJORKMAN S, HOGLUND P. Clinical pharmacology of thalidomide[ J]. Eur J Clin Phamlacol,2001,57 (5) :365-376.
  • 2RAJKUMAR SV. Current status of thalidomide in the treatment of cancer[J]. Oncology(Huntingt) ,2001,15(7) :867-874.
  • 3OSMAN K, COMENZO R, RAJKUMAR SV. Deep venous thrombosis and thalidomide therapy for multiple myeloma[ J]. N Engl J Med, 2001,344(25) :1951-1952.
  • 4MEIERHOFER C, DUNZENDORFER S, WIEDERMANN C J. Theoretical basis for the activity of thalidomide[ J]. BioDrugs,2001,15 (10) :681-703.
  • 5GACHON J, GROB JJ, RICHARD MA. Thrombotic accidents induced by thalidomide: two cases [ J ]. Rev Med Interne,2002,23 : 724.
  • 6Nadir Y, Katz T, Sarig G, et al. Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor. Haematologica, 2005; 90 ( 11 ) : 1549 - 1556.
  • 7Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med,2003 ;9(4 ) :458 -462.
  • 8Zhu J, Guo WM, Yao YY, et aL Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia, 1999 ; 13 (7) : 1062 - 1070.
  • 9Poitevin S, Cochery-Nouvellon E, Dupont A, et al. Monocyte/L- 10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles. Thromb Haemost,2007 ;97(4) : 598 - 607.
  • 10Szotowski B, Antoniak S, Poller W, et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res,2005,96(12) :1233 -1239.

共引文献11

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部